Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2011

The Vitreous Glycoprotein Opticin Inhibits Extracellular Matrix-driven Angiogenesis

Magali M. Le Goff; Matthew Sutton; Mark Slevin; Martin J. Humphries; Paul N. Bishop

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4843. doi:

ARVO Annual Meeting Abstract May 2008

Opticin Inhibits Preretinal Neovascularisation by Disrupting Pro-Angiogenic Signalling by Collagen

M. M. Le Goff; M. Sutton; M. Slevin; M. J. Humphries; P. N. Bishop

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):520. doi:

ARVO Annual Meeting Abstract May 2006

The Vitreous Glycoprotein Opticin Binds 2ß1 Integrin and Disrupts Capillary Morphogenesis

M.M. Le Goff; M.A. Slevin; M.J. Humphries; P.N. Bishop

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5342. doi:

ARVO Annual Meeting Abstract May 2005

Opticin Is an Inhibitor of VEGF–A and FGF–2–Activated Angiogenesis

M.M. Le Goff; M.A. Slevin; P.N. Bishop

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):451. doi:

ARVO Annual Meeting Abstract May 2004

The anti–angiogenic effects of opticin, a glycoprotein in the vitreous humour of the eye.

M.M. Le Goff; M.A. Slevin; P.N. Bishop

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1915. doi:

Advertisement